[News] Gut microbiome and immunotherapy response

A new study by Vancheswaran Gopalakrishnan (MD Anderson Cancer Center, Houston, TX, USA) and colleagues has found that the composition of the gut microbiome affects the way patients with advanced melanoma respond to anti-PD-1 immunotherapy.

Source: The Lancet Oncology - November 9, 2017 Category: Cancer & Oncology Authors: Talha Khan Burki Tags: News Source Type: research